Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease

di Punzi, L, Podswiadek, M, D'Inca, R, Zaninotto, M, Bernardi, D, Plebani, M, Sturniolo, G
Pubblicazione 2003

Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors – A cross-sectional study

di Marinelli, C., Savarino, E. V., Marsilio, I., Lorenzon, G., Gavaruzzi, T., D’Incà, R., Zingone, F.
Pubblicato in Sci Rep (2020)

Effect of live yeast Saccharomyces cerevisiae (Actisaf Sc 47) supplementation on the performance and hindgut microbiota composition of weanling pigs

di Kiros, T. G., Derakhshani, H., Pinloche, E., D’Inca, R., Marshall, Jason, Auclair, E., Khafipour, E., Van Kessel, A.
Pubblicato in Sci Rep (2018)

Altered Chemokine Signalling in Endothelial Progenitor Cells from Acute Ulcerative Colitis Patients

di De Toni, L., Di Nisio, A., Magagna, S., Michielan, A., Martinato, M., Sturniolo, G. C., D'Incà, R., Foresta, C., Garolla, A.
Pubblicato in Gastroenterol Res Pract (2015)

Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases

di Cucchiara, S, Latiano, A, Palmieri, O, Staiano, AM, D’Incà, R, Guariso, G, Vieni, G, Rutigliano, V, Borrelli, O, Valvano, MR, Annese, V
Pubblicazione 2007

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth

di Gatta, L., Scarpignato, C., McCallum, R.W., Lombardo, L., Pimentel, M., D'Incà, R., Gasbarrini, A., De Stefano, A., Cerda, E.
Pubblicato in Aliment Pharmacol Ther (2017)